Full Breakdown
Rising Private Prescriptions for ADHD Medication in Northern Ireland
12/23/2025, 4:31:10 AM
Surge in Private Prescriptions
In Northern Ireland, the number of private prescriptions for Attention Deficit Hyperactivity Disorder (ADHD) medication has surged dramatically, with nearly 4,000 prescriptions issued in 2024, a stark increase from just six in 2019. Data from the Health and Social Care (HSC) Business Services Organisation (BSO) indicates that almost half of these prescriptions were supplied by clinics based outside Northern Ireland. While the National Health Service (NHS) continues to issue a significantly higher volume of ADHD medication—89,128 prescriptions last year—private prescribing is growing at a faster rate, driven largely by patients seeking to bypass lengthy NHS waiting lists.
Factors Driving the Shift to Private Care
Patients like Keith Lawrence, a network engineer from Lisburn, have turned to private clinics due to unacceptable waiting times for NHS assessments. Lawrence faced a five-year wait, which later extended to between seven and ten years. He opted for an online private clinic in England, where he received a diagnosis of inattentive ADHD and was prescribed methylphenidate, the most commonly prescribed medication for ADHD. The private assessment process included detailed questionnaires and a video consultation, which Lawrence found thorough and beneficial.
Katie Graden-Tyson, a social work assistant from Belfast, is also considering private assessment due to the NHS wait times, which she estimates could take up to ten years. She acknowledges that while medication is a last resort for her, the prospect of waiting indefinitely for support is untenable.
Official Responses and Concerns
The Department of Health (DoH) has acknowledged the growing waiting times for ADHD diagnoses, labeling the situation as "unacceptable." A spokesperson stated that actions are being taken to improve the situation, including a report set to be published next year to assess the demand for an ADHD commissioned service.
Dr. Frances O'Hagan, chair of the British Medical Association (BMA) Northern Ireland GP committee, expressed concerns about the quality of assessments conducted by private providers. She noted that while NHS assessments are typically detailed and face-to-face, there is no guarantee that private assessments meet the same standards. The DoH advises that patients seeking private diagnoses should not expect the NHS to take over their care, as GPs may refuse to prescribe medications initiated by private clinics.
Criticism of Private Care Practices
Critics argue that the rise in private prescriptions reflects systemic failures within the NHS rather than an increase in ADHD prevalence. Dr. O'Hagan emphasized that shared care arrangements between GPs and private providers are not recommended due to the lack of NHS specialists available for oversight. This situation raises concerns about the continuity and quality of care for patients who choose private routes.
Conclusion
The significant rise in private ADHD prescriptions in Northern Ireland highlights a growing reliance on private healthcare services amid inadequate NHS provisions. As patients continue to seek timely diagnoses and treatment, the implications for public health policy and service delivery remain critical.
